A patient is scheduled for a hypophysectomy due to a pituitary neoplasm.
What is the most important postoperative nursing intervention to monitor for complications after this surgery?

Choice A rationale

While notifying the healthcare provider is necessary, it is not the most immediate priority when the patient shows signs of hemodynamic instability. The nurse must first intervene to stabilize the patient's circulatory volume. Postoperative patients who have had surgery for Cushing's disease are at high risk for acute adrenal insufficiency. This occurs because the remaining adrenal tissue may be atrophied and unable to produce sufficient cortisol, leading to a life-threatening addisonian crisis.

Choice B rationale

Increasing oxygen flow may be supportive, but it does not address the underlying physiological cause of low blood pressure and tachycardia in this specific postoperative context. The primary issue is likely a lack of circulating cortisol and subsequent fluid volume deficit or vasodilation. While maintaining oxygen saturation is part of standard PACU care, it will not correct the hypotension or the potential adrenal crisis that is developing, making it a secondary intervention in this scenario.

Choice C rationale

Encouraging deep breaths is a standard intervention to prevent atelectasis and improve respiratory function after general anesthesia. However, it is not a priority when the patient is exhibiting signs of shock, such as hypotension and tachycardia. These vital sign changes suggest a cardiovascular or endocrine emergency rather than a primary respiratory problem. The nurse must focus on interventions that will restore blood pressure and ensure adequate organ perfusion to prevent further deterioration.

Choice D rationale

Administering IV fluids is the priority action to treat hypotension and tachycardia, which are signs of potential acute adrenal insufficiency or hypovolemia. In the absence of high cortisol levels after removing a tumor, the body cannot maintain vascular tone or fluid balance effectively. Rapid fluid resuscitation helps restore circulating volume and blood pressure. Following fluid initiation, the nurse should also prepare to administer parenteral hydrocortisone as ordered to replace the missing adrenal hormones.

Choice A rationale

Hydroxychloroquine is an antimalarial and immunomodulator that can affect the immune response. While it is not as profoundly immunosuppressive as high-dose corticosteroids or biologics, receiving live-attenuated vaccines like MMR (measles, mumps, rubella) while on therapy requires cautious clinical judgment. The patient's statement that they can "safely" receive them without qualification suggests a potential misunderstanding of how the drug affects the immune system's ability to respond to live pathogens, which could lead to vaccine-induced illness.

Choice B rationale

Hydroxychloroquine can cause retinal toxicity, leading to irreversible vision loss if not detected early. This occurs due to the drug binding to melanin in the retinal pigment epithelium. A baseline ophthalmic exam is required within the first year of starting therapy to document any pre-existing conditions. Follow-up exams, typically annually after five years of use or sooner if high-risk factors exist, are essential to monitor for early signs of retinopathy, ensuring the medication is discontinued before permanent damage.

Choice C rationale

Alcohol consumption is generally discouraged while taking hydroxychloroquine because both substances are metabolized by the liver. Chronic alcohol use can increase the risk of hepatotoxicity and may exacerbate the gastrointestinal side effects of the medication, such as nausea or abdominal cramps. Furthermore, systemic lupus erythematosus itself often involves multi-organ systems, including the liver. Suggesting that unlimited alcohol intake is safe demonstrates a lack of understanding regarding the metabolic demands placed on the body during pharmacological therapy.

Choice D rationale

Visual changes, such as blurred vision, halos around lights, or difficulty focusing, are never considered harmless side effects of hydroxychloroquine. These symptoms may indicate early retinal damage or corneal deposits. If a patient experiences any alteration in their visual field, they must report it immediately to their healthcare provider and stop the medication until an ophthalmologist can perform a thorough evaluation. Dismissing these symptoms as expected side effects could lead to permanent blindness for the client.